Norwegian study on spontaneous coronary artery dissection
Part of Heart & circulation clinical trials.
This trial is for people who have had a spontaneous coronary artery dissection (SCAD), a tear in a heart artery. It aims to learn more about this condition and how to treat it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have had a spontaneous coronary artery dissection (SCAD).
- You cannot have severe kidney failure.
- You cannot have a severe allergy to contrast dye (used in imaging tests).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people admitted with a recent heart event (STEMI, NSTEMI, or unstable angina) and who were found to have SCAD on a heart scan. It may help doctors better understand and manage SCAD after these urgent events.
This study looks at genetic (inherited) causes of spontaneous coronary artery dissection (SCAD) in families. It may help researchers understand why SCAD happens and how it could be prevented or identified earlier in others.
This study is a virtual registry (a way to collect and track real-world health information) for people diagnosed with SCAD at Mayo Clinic. It may help researchers better understand SCAD in groups that are often underrepresented and in urgent, recent cases.
This trial compares different intensities of antiplatelet therapy for people who had a heart attack caused by a spontaneous tear in a heart artery (SCAD). It aims to find the best balance between preventing clots and avoiding bleeding risks.
This study tests whether a supervised exercise program is safe and helpful for people who have had a spontaneous coronary artery dissection (SCAD), a tear in a heart artery. It may help improve your recovery and heart health.
This study collects information from people diagnosed with spontaneous coronary artery dissection (SCAD) in the last 10 years. It aims to learn more about this rare heart condition to improve future care.
Hear when a new SCAD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.